Genky DrugStores Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
Genky DrugStores Co., Ltd. carries a market capitalization of 109.12B, placing it among publicly traded companies globally. Its enterprise value stands at 120.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 109.12B |
| Enterprise Value | 120.90B |
Share Statistics
Genky DrugStores Co., Ltd. currently has 30.40M shares outstanding.
| Shares Outstanding | 30.40M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Genky DrugStores Co., Ltd. trades at a trailing price-to-earnings ratio of 29.33. The price-to-sales ratio is 1.02, and the price-to-book ratio stands at 2.16.
| PE Ratio | 29.33 |
| PS Ratio | 1.02 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 1.92 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Genky DrugStores Co., Ltd. trades at an EV/EBITDA multiple of 26.12 and an EV/FCF ratio of 2,715.20. The EV/Sales ratio of 1.30 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.12 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.30 |
| EV / EBITDA | 26.12 |
| EV / EBIT | 26.12 |
| EV / FCF | 2,715.20 |
Financial Position
Genky DrugStores Co., Ltd. maintains a current ratio of 0.99, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 66.08, indicating elevated leverage, while an interest coverage ratio of 77.13 demonstrates strong ability to service its debt obligations.
| Current Ratio | 0.99 |
| Quick Ratio | 0.17 |
| Debt / Equity | 66.08 |
| Debt / EBITDA | 7.11 |
| Interest Coverage | 77.13 |
Financial Efficiency
Genky DrugStores Co., Ltd. posts a return on equity of 7.91 and a return on invested capital of 4.27.
| Return on Equity (ROE) | 7.91 |
| Return on Assets (ROA) | 2.84 |
| Return on Invested Capital (ROIC) | 4.27 |
| Return on Capital Employed (ROCE) | 4.50 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.92 |
Taxes
Over the trailing twelve months, Genky DrugStores Co., Ltd. has paid 1.13B in income taxes, reflecting an effective tax rate of 25.79.
| Income Tax | 1.13B |
| Effective Tax Rate | 25.79 |
Stock Price Statistics
Genky DrugStores Co., Ltd.'s stock has declined approximately -12.3623% over the past 52 weeks. The 50-day moving average sits at 3,488.60, while the 200-day moving average is 4,323.88.
| Beta (5Y) | N/A |
| 52-Week Price Change | -12.3623% |
| 50-Day Moving Average | 3,488.60 |
| 200-Day Moving Average | 4,323.88 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Genky DrugStores Co., Ltd. generated 92.89B in revenue and converted that into 3.24B in net income, yielding earnings per share of 106.35. EBITDA reached 4.63B, while operating income came in at 4.63B.
| Revenue | 92.89B |
| Gross Profit | 18.84B |
| Operating Income | 4.63B |
| Pretax Income | 4.36B |
| Net Income | 3.24B |
| EBITDA | 4.63B |
| EBIT | 4.63B |
| Earnings Per Share (EPS) | 106.35 |
Balance Sheet
Genky DrugStores Co., Ltd. holds 6.94B in cash and equivalents against 32.90B in total debt, resulting in a net debt position of 25.96B. Total book value stands at 43.97B, with working capital of -328.00M providing operational flexibility.
| Cash & Cash Equivalents | 6.94B |
| Total Debt | 32.90B |
| Net Debt | 25.96B |
| Equity (Book Value) | 43.97B |
| Book Value Per Share | 1,447.28 |
| Working Capital | -328.00M |
Margins
Genky DrugStores Co., Ltd. operates with a gross margin of 20.28, reflecting its pricing power and cost economics. The operating margin of 4.98 and net profit margin of 3.48 provide insight into operational efficiency.
| Gross Margin | 20.28 |
| Operating Margin | 4.98 |
| Pretax Margin | 4.70 |
| Profit Margin | 3.48 |
| EBITDA Margin | 4.98 |
Stock Splits
Genky DrugStores Co., Ltd.'s most recent stock split took place on June 19, 2024 with a 1:2 split ratio.
| Last Split Date | 6/19/2024 |
| Split Ratio | 1:2 |
Scores
Genky DrugStores Co., Ltd. posts an Altman Z-Score of 2.22, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.22 |